Clinical Trials Logo

Clinical Trial Summary

Assessment of efficacy and safety for a new wound dressing URGO 310 3166 in the local treatment of venous or mixed leg ulcers: a European, randomised clinical trial.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02583958
Study type Interventional
Source Laboratoires URGO
Contact Sylvie Meaume, MD
Email sylvie.meaume@rth.aphp.fr
Status Recruiting
Phase N/A
Start date October 2014
Completion date June 2017

See also
  Status Clinical Trial Phase
Terminated NCT00762138 - The AutoloGelâ„¢ Post-Market Surveillance (TAPS) Program N/A
Completed NCT00007280 - Bioengineered Skin and Wound Healing Phase 1
Completed NCT01238419 - Physiotulle vs Urgotul in the Treatment of Leg Ulcer Phase 4
Active, not recruiting NCT05561140 - Resolution of Sickle Cell Leg Ulcers With Voxelotor Phase 3
Completed NCT00628004 - Safety Evaluation of Biatain Ibu in Painful Chronic Venous Leg Ulcers N/A
Completed NCT00710489 - Potential Research Study Participant Registry
Completed NCT00821431 - Compression Device Versus 4-layer Compression System Phase 2
Not yet recruiting NCT00922389 - A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb Ischemia Phase 1/Phase 2
Completed NCT00184873 - Legtest Multi Centre Testing of the Lively Legs Program for Promoting Compliance in Leg Ulcer Patients N/A
Completed NCT00807664 - Biatain Ag vs Biatain in the Treament of Leg Ulcers N/A
Completed NCT01427491 - Compare Aquacel® Ag Versus Mepilex® Border Ag to Manage Bioburden in Leg Ulcers Phase 3
Completed NCT00522002 - CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study N/A
Completed NCT02632695 - Physical Activity Interventions for Leg Ulcer Patients N/A